Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference
Author
Summary, in English
Diamond Blackfan anaemia (DBA) is a rare, genetically and clinically heterogeneous, inherited red cell aplasia. Classical DBA affects about seven per million live births and presents during the first year of life. However, as mutated genes have been discovered in DBA, non-classical cases with less distinct phenotypes are being described in adults as well as children. In caring for these patients it is often difficult to have a clear understanding of the treatment options and their outcomes because of the lack of complete information on the natural history of the disease. The purpose of this document is to review the criteria for diagnosis, evaluate the available treatment options, including corticosteroid and transfusion therapies and stem cell transplantation, and propose a plan for optimizing patient care. Congenital anomalies, mode of inheritance, cancer predisposition, and pregnancy in DBA are also reviewed. Evidence-based conclusions will be made when possible; however, as in many rare diseases, the data are often anecdotal and the recommendations are based upon the best judgment of experienced clinicians. The recommendations regarding the diagnosis and management described in this report are the result of deliberations and discussions at an international consensus conference.
Department/s
Publishing year
2008
Language
English
Pages
859-876
Publication/Series
British Journal of Haematology
Volume
142
Issue
6
Links
Document type
Journal article review
Publisher
Wiley-Blackwell
Topic
- Hematology
Keywords
- cancer predisposition
- Diamond Blackfan anaemia
- bone marrow failure
- genetics
- treatment
Status
Published
ISBN/ISSN/Other
- ISSN: 0007-1048